ArticleJournal for immunotherapy of cancer2024

Therapeutic Inducers of Natural Killer cell Killing (ThINKK): preclinical assessment of safety and efficacy in allogeneic hematopoietic stem cell transplant settings.

Nicolas Poirier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.